Longevity
The Senescence-Cancer Crossover: A Metabolic Brake on Aging Cells
New 2025 research reframes senescent and tumor cells as biological cousins — and points to putrescine as an unexpected checkpoint in how cells decide to age.
senolytics
Longevity
Senolytics Go Mainstream: Killing Zombie Cells to Save Aging Bones
Two 2025 studies converge on a striking thesis — that clearing senescent cells, with drugs or even intermittent pressure, may halt age-related bone loss in mice. Here's what the preclinical signal actually says.
Longevity
Senotherapeutics 2.0: A Reishi Molecule, Rapamycin's Shadow, and the AI Hunt for Anti-Aging Drugs
A reishi-derived compound matched rapamycin in worms and rejuvenated aged mice. A parallel review maps how machine learning is industrializing the search for the next generation of senolytics.
Longevity
The New Aging Hallmarks: Why Lysosomes, Senescent Cells, and Translation Errors Are the Next Frontier
Three 2025 papers are quietly reshaping the science of why we age — and where the next generation of interventions may aim. Here is what to know, and what to hold loosely.